Response from the authors to: Identification of paroxysmal atrial fibrillation also for primary prevention of embolic stroke

The CRYSTAL AF trial is an important step in this process, and we agree with the authors that extending this technology for the primary prevention of stroke in high-risk patients is worthy of further study.

Saved in:
Bibliographic Details
Published in:The American heart journal 2010-12, Vol.160 (6), p.e45-e45
Main Authors: Sinha, Anil-Martin, MD, DPhil, Brachmann, Johannes, MD, PhD, Diener, Hans-Christoph, MD, PhD, Morillo, Carlos A., MD, Sanna, Tommaso, MD, Bernstein, Richard A., MD, Di Lazzaro, Vincenzo, MD, Passman, Rod, MD, Rymer, Marilyn, MD, Beckers, Frank, PhD
Format: Article
Language:English
Subjects:
Cardiac arrhythmia
Cardiovascular
Drug therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The CRYSTAL AF trial is an important step in this process, and we agree with the authors that extending this technology for the primary prevention of stroke in high-risk patients is worthy of further study.
ISSN:0002-8703
1097-6744
DOI:10.1016/j.ahj.2010.09.006